Your body is under metabolic stress
The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist 1 , 2 Yoo La Lee, 3 and Chang Hee Jung 1 , 2 Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings
However, like any medication, it may cause side effects in some people
Pancreatitis (inflammation of the pancreas) can happen as well
Yang S, Shen W, Zhang HZ, Wang CX, Yu WQ, Wu QH
To view a copy of this licence, visit About this article Cite this article Oettinger, V., von zur Mhlen, C., Kaier, K